Literature DB >> 8131767

Feasibility of assessing regional myocardial uptake of 18F-fluorodeoxyglucose using single photon emission computed tomography.

J J Bax1, F C Visser, A van Lingen, J M Huitink, O Kamp, G R van Leeuwen, G W Visser, G J Teule, C A Visser.   

Abstract

Differentiation between viable myocardium and scar tissue in segments with abnormal contraction has important consequences in the clinical management of patients with coronary artery disease. Positron emission tomography (PET) can identify viable tissue using 18F-fluorodeoxyglucose (FDG). However, application of PET for daily routine is limited. In this study, FDG uptake was visualized with single photon emission computed tomography (SPECT) and compared with regional perfusion assessed with thallium-201 (201Tl) SPECT. The scintigraphic findings were related to regional wall motion determined with two-dimensional echocardiography. Patients (n = 9) with wall motion abnormalities underwent FDG SPECT and resting 201Tl SPECT. To control the metabolic status patients were studied with a hyperinsulinaemic euglycemic clamp during FDG SPECT. Analysis of reconstructed data was performed visually and semiquantitatively using circumferential profiles. High-quality images were obtained. Eight 201Tl defects showed concordantly decreased FDG uptake (metabolism-perfusion matches) indicating scarred tissue, whereas six regions of hypoperfusion demonstrated a relatively increased FDG uptake (mismatches), suggesting viable myocardium. Semiquantitative analysis confirmed visual findings. Mean 201Tl and FDG activities were not significantly different in matching defects. In mismatches the mean FDG activity was 81 +/- 11% vs 64 +/- 9% mean 201Tl activity (P < 0.0001). In four of six segments with increased FDG uptake, two-dimensional echo revealed hypokinesia. Seven of eight regions with a matching defect in contrast were akinetic. Thus, in the areas with a mismatch contractility was preserved. We conclude that FDG uptake can be visualized with SPECT. Furthermore, our preliminary observations suggest that this approach can identify viable tissue.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8131767     DOI: 10.1093/eurheartj/14.12.1675

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  14 in total

Review 1.  Fluorine-18-deoxyglucose SPECT and coincidence imaging for myocardial viability: Clinical and technologic issues.

Authors:  V Dilsizian; S L Bacharach; M M Khin; M F Smith
Journal:  J Nucl Cardiol       Date:  2001 Jan-Feb       Impact factor: 5.952

Review 2.  Cellular and molecular regulation of cardiac glucose transport.

Authors:  L H Young; D L Coven; R R Russell
Journal:  J Nucl Cardiol       Date:  2000 May-Jun       Impact factor: 5.952

3.  F18-fluorodeoxyglucose single-photon emission computed tomography predicts functional outcome of dyssynergic myocardium after surgical revascularization.

Authors:  J J Bax; J H Cornel; F C Visser; P M Fioretti; J M Huitink; A van Lingen; G W Sloof; C A Visser
Journal:  J Nucl Cardiol       Date:  1997 Jul-Aug       Impact factor: 5.952

4.  Relation between myocardial uptake of thallium-201 chloride and fluorine-18 fluorodeoxyglucose imaged with single-photon emission tomography in normal individuals.

Authors:  J J Bax; F C Visser; A van Lingen; A B Groeneveld; J M Huitink; G J Teule; C A Visser
Journal:  Eur J Nucl Med       Date:  1995-01

Review 5.  Fluorine 18-labeled fluorodeoxyglucose myocardial scintigraphy with Anger gamma cameras for assessing myocardial viability.

Authors:  M J Kelly; V Kalff
Journal:  J Nucl Cardiol       Date:  1995 Jul-Aug       Impact factor: 5.952

6.  Improved detection of viable myocardium with fluorodeoxyglucose-labeled single-photon emission computed tomography in a patient with hibernating myocardium: comparison with rest-redistribution thallium 201-labeled single-photon emission computed tomography.

Authors:  J J Bax; F C Visser; J H Cornel; A van Lingen; P M Fioretti; C A Visser
Journal:  J Nucl Cardiol       Date:  1997 Mar-Apr       Impact factor: 5.952

7.  Assessment of myocardial viability using F-18 fluorodeoxyglucose/Tc-99m sestamibi dual-isotope simultaneous acquisition SPECT: comparison with Tl-201 stress-reinjection SPECT.

Authors:  Yen-Wen Wu; Por-Jau Huang; Chii-Ming Lee; Yi-Lwun Ho; Lung-Chun Lin; Tzung-Dau Wang; Shoei-Shen Wang; Tony Hsiu-Hsi Chen; Ruoh-Fang Yen
Journal:  J Nucl Cardiol       Date:  2005 Jul-Aug       Impact factor: 5.952

8.  Electrocardiographic-gated dual-isotope simultaneous acquisition SPECT using 18F-FDG and 99mTc-sestamibi to assess myocardial viability and function in a single study.

Authors:  Ichiro Matsunari; Sugako Kanayama; Tatsuya Yoneyama; Masamichi Matsudaira; Kenichi Nakajima; Junichi Taki; Stephan G Nekolla; Norihisa Tonami; Kinichi Hisada
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-09-21       Impact factor: 9.236

9.  Fast 18F labeling of a near-infrared fluorophore enables positron emission tomography and optical imaging of sentinel lymph nodes.

Authors:  Richard Ting; Todd A Aguilera; Jessica L Crisp; David J Hall; William C Eckelman; David R Vera; Roger Y Tsien
Journal:  Bioconjug Chem       Date:  2010-10-20       Impact factor: 4.774

Review 10.  Metabolic imaging using PET.

Authors:  Takashi Kudo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-05-05       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.